CClinicalTrials.gg
CompletedNCT01736384Updated Feb 28, 2020

Can Genetic Markers Predict Weight Loss After Gastric By-pass Surgery

An observational study in Obesity, sponsored by Karolinska Institutet. Completed at 3 sites in Sweden. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-02-28.

Sponsored by Karolinska Institutet · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
2,000
Ages
18 Years to 65 Years
Sex
All
01

Study summary

There is a variability in weight loss after gastric bypass surgery for obesity despite a standardised surgical procedure. This study aims to investigate if genetic markers can predict outcome after gastric by-pass surgery in treatment of obesity. The investigators will also study if adenovirus infection can influence the outcome after surgery. In a subgroup of patients, hormonal changes after gastric by-pass surgery will be assessed. Lipid and protein patterns will be assessed in plasma and tissues. Omental and subcutaneous fat as well as liver biopsies and whole blood are stored in a biobank. The same tissues will be collected from non-obese controls undergoing gallbladder surgery.

02

Conditions studied

  • Obesity

Browse trials for

03

In context

Weight Loss

1,766 studies on the registry are indexed under Weight Loss; 277 are open to participants now.

This study's enrollment of 2,000 is above the median of 92 across 219 observational studies indexed under Weight Loss.

Browse Weight Loss studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Obesity

Inclusion criteria

  • laparoscopic gastric by-pass with BMI greater than 35

Exclusion criteria

Exclusion Criteria:

  • unable to understand swedish
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
2,000 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • Obesity

    Gastric bypass surgery and non-obese controls undergoing cholecystectomy

    Procedure: Gastric bypass or cholecystectomy

Interventions

  • ProcedureGastric bypass or cholecystectomy
06

What researchers measure

Primary outcomes

  1. Genetic markers

    Blood samples and tissue biopsies taken at the time of surgery and at follow-up.

    Time frame: day of surgery and 1 and 2 years after surgery

Secondary outcomes

  1. Lipid and protein patterns in plasma and tissues

    Blood samples taken and tissue biopsies taken at the time of surgery and at follow-up

    Time frame: day of surgery and at 1 and 2 years postoperatively

  2. Previous viral infection

    Blood samples taken before surgery

    Time frame: At time of surgery

  3. Genexpression and comorbid disease

    Gene expression studies in tissue biopsies and whole blood at time of surgery and follow-up

    Time frame: At time of bariatric surgery and 1-2 years postoperatively

07

Study locations

3 sites
  • Karolinska Institutet, Ersta Hospital
    Stockholm, SE-116 91, Sweden
  • Karolinska Institutet, Danderyds Hospital
    Stockholm, SE-182 88, Sweden
  • Karolinska University Hospital
    Stockholm, Sweden
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01736384
Lead sponsor
Karolinska Institutet
Collaborators
Danderyd Hospital, Ersta Hospital, Sweden, Karolinska University Hospital
Responsible party
Erik Näslund (Professor, Karolinska Institutet) — Principal investigator
First posted
Nov 29, 2012
Start date
Feb 2009
Primary completion
Feb 2020
Completion
Feb 2020
Last update
Feb 28, 2020

Study contacts

Erik Näslund, Professor
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion